Apr 15, 2020 - If successful, the Sanofi (SNY) and GlaxoSmithKline plc (GSK) vaccine would be available in the second half of 2021. Shares of drugmakers jumped on the news.
Apr 15, 2020 - Top Stock Reports for Microsoft, Walmart & Amgen
Apr 17, 2020 - Treatment with Gilead's (GILD) experimental antiviral, remdesivir, shows rapid recoveries in fever and respiratory symptoms in COVID-19 patients in a Chicago hospital.
Apr 20, 2020 - This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?
Apr 22, 2020 - Solid sales of Roche's (RHHBY) new drugs in the first quarter more than offset the competition from biosimilars.
Apr 24, 2020 - In Pfizer's (PFE) Biopharma unit, oncology sales are likely to have risen in the first quarter, while in non-oncology, Xeljanz and Eliquis alliance revenues are likely to have supported the top line.
May 04, 2020 - In a short span of time, Gilead's Remdesivir has been successful in treating some coronavirus patients. But will this give a boost to the pharmaceutical giant?
Aug 26, 2020 - The S&P 500 and the Nasdaq hit an all-time high on Tuesday, while the Dow declined amid mixed economic news and decline in heavy weights like Exxon Mobil and Boeing.
Sep 01, 2020 - U.S. stock markets closed mostly lower on Monday as investors booked profit after a week-long rally.
Sep 21, 2020 - Biotech firms and drugmakers across the globe are pumping in millions of dollars to develop a vaccine to wipe out the deadly coronavirus.